Phoenix
  • News
  • About
  • Investments
  • Team
  • Partners
  • Contact
Select Page
Autonomic Materials raises $3M round and Mark Johnson joins the Board of Directors

Autonomic Materials raises $3M round and Mark Johnson joins the Board of Directors

Jun 13, 2022

CHAMPAIGN, Ill., June 13, 2022 /PRNewswire/ — Autonomic Materials, Inc. (AMI), the leading developer and provider of self-healing, ESG compatible smart coatings incorporating proprietary and patented microencapsulation technology, announces the successful...
Sonic Incytes Announces Velacur™️ use in Madrigal Pharmaceuticals’ Open-Label Extension Clinical Trial

Sonic Incytes Announces Velacur™️ use in Madrigal Pharmaceuticals’ Open-Label Extension Clinical Trial

Jun 13, 2022

Sonic Incytes Medical Corp. is pleased to announce the inclusion of VelacurTM — the first handheld 3D liver health assessment tool—in a subset of Madrigal Pharmaceutical’s MAESTRO NAFLD-1 Phase 3 Open Label Extension study of resmetirom (MGL-3196-18). As part of this...
1st Inkbit Vista 3D Printer Operational at Saint-Gobain Research North America

1st Inkbit Vista 3D Printer Operational at Saint-Gobain Research North America

Jun 10, 2022

Marking the finish line of a marathon lasting the better part of a decade, Medford, MA-based 3D printer startup Inkbit has announced that the first commercial Vista printer to be installed is now operational. Inkbit’s inaugural customer is Saint-Gobain, the French...
L7 Informatics Raises $38 Million Growth Investment to Digitalize Precision Healthcare

L7 Informatics Raises $38 Million Growth Investment to Digitalize Precision Healthcare

Jun 7, 2022

AUSTIN, Texas, June 7, 2022 /PRNewswire/ — L7 Informatics, a leader in software for life sciences that delivers a flexible end-to-end platform for precision healthcare, today announced a $38 million investment led by Banneker Partners with participation from its...
Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics

Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics

May 20, 2022

WOBURN, Mass., May 20, 2022–(BUSINESS WIRE)–Comera Life Sciences Holdings, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and...
Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics

Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation

May 10, 2022

WOBURN, Mass.—(BUSINESS WIRE)—Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced it has entered into a research...
« Older Entries

Recent Posts

  • Autonomic Materials raises $3M round and Mark Johnson joins the Board of Directors
  • Sonic Incytes Announces Velacur™️ use in Madrigal Pharmaceuticals’ Open-Label Extension Clinical Trial
  • 1st Inkbit Vista 3D Printer Operational at Saint-Gobain Research North America
  • L7 Informatics Raises $38 Million Growth Investment to Digitalize Precision Healthcare
  • Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics

Categories

  • Article
  • Interview
  • News
  • Press Release
  • Show All
Manage Cookie Consent
Please note that use of this website is subject to your acceptance of the Terms and Conditions of use and Privacy Policy. I am not a resident of the European Union.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}